Abstract: It has been observed that a distinct blood pressure (BP) response to prolonged and forced hyperventilation in adult patients with essential hypertension is associated with significant changes in plasma catecholamine and β-endorphin levels. This paper investigated whether hemodynamic and neuro-endocrine responses to hyperventilation in elderly patients with essential hypertension (n = 39, mean age 81 ± 3 years) differ from those in elderly patients with secondary hypertension (isolated systolic hypertension, bilateral chronic nephropathy, nephroangiosclerosis, diabetic nephropathy and hyperparathyroidism) (n = 39, mean age 80 ± 1 years). Plasma β-endorphin levels were normal in patients with essential hypertension and increased in patients with secondary hypertension. Plasma norepinephrine levels were normal in both populations. Hyperventilation decreased BP and norepinephrine levels and increased β-endorphin levels in essential hypertensive patients, whereas it did not significantly change BP or neuro-hormonal levels in secondary hypertensive patients. Hierarchical cluster analysis based on BP response to hyperventilation disclosed a sub-group of essential hypertensive patients with the highest basal levels of norepinephrine and the lowest β-endorphin levels, in whom the BP decrease following hyperventilation was correlated with the decrease in norepinephrine and increase in β-endorphin levels. This suggests that b-endorphin may be involved in modulating sympatho-adrenergic activity in elderly patients with essential hypertension.
Introduction
Increased sympatho-adrenergic activity and an associated hemodynamic response to pressor stimuli are characteristic of elderly normotensive subjects [1, 2] and elderly hypertensive patients [3, 4] . Plasma β-endorphin levels have been found reduced or normal in elderly essential hypertensive patients [5] [6] [7] , whereas increased levels were reported in elderly secondary hypertensive patients with chronic renal failure [8, 9] .
Functional studies have shown that opioid peptides are involved in regulating sympatho-adrenergic activity [10, 11] . Different forms of stress activate the endogenous opioid system that, in turn, contributes to changes in systemic cardiovascular function [12] [13] [14] .
The relation between cardiovascular parameters, the sympatho-adrenergic system and endogenous opiates have recently been studied using the forced hyperventilation test [6, 15, 16] . Five minutes of forced hyperventilation induce different blood pressure (BP) responses, dividing healthy subjects [15] and adult patients with mild or moderate essential hypertension [6, 16] into three groups: the first responding with a Cent. Eur. J. Med. • 3(1) • 2008 • 55-63 DOI: 10.2478/s11536-007-0071-x decrease in BP, the second without any significant change, and the third with an increase. The hemodynamic effects of the hyperventilation test depend on different sympatho-adrenergic reactivity as supported by the correlations between the changes in pressor responses and plasma catecholamine levels [6, 15, 16] . The decrease in BP and plasma catecholamine levels in response to hyperventilation is associated with an increase in β-endorphin levels. The infusion of an opioid antagonist, naloxone, abolishes the hyperventilationinduced BP and norepinephrine decrease, indicating a role of the endogenous opioid system in modulating sympatho-adrenergic activity [6] .
Considering the involvement of the autonomic nervous system in BP response to the hyperventilation test and the increased sympatho-adrenergic activity observed in elderly subjects, we evaluated whether BP responses to hyperventilation change with aging in patients with essential hypertension. In addition, we investigated elderly patients with secondary hypertension to evaluate whether different mechanisms inducing hypertension disclose distinct BP and neuroendocrine responses to the test and whether these responses will improve the diagnostic management of elderly hypertensive patients.
Material and Methods

Patients
We enrolled 78 elderly antihypertensive drug-free patients (39 with essential hypertension of grades 1 and 2 according to the Sixth Report of the Joint National Committee and the World Health Organization, JNC VI/ WHO [17] , and 39 with secondary hypertension). The patients' clinical and neuro-hormonal characteristics are summarised in Table 1 . Patients were recruited from: (1) patients with a first diagnosis of hypertension, (2) hypertensive patients after discontinuation of antihypertensive drugs during hospital admission for clinical and instrumental monitoring to adjust suboptimal antihypertensive therapy. The patients with essential hypertension were included in the study only if they had normal plasma creatinine values (≤1.2 mg/dl). Patients with nephroangiosclerosis were selected on the basis of plasma creatinine values >1.7 mg/dl, abnormal renal echogenicity and vascular resistance index >0.75.
All patients were in sinus rhythm. Twenty patients with essential hypertension and 23 with secondary hypertension presented electrocardiographic or echocardiographic signs of septal or left ventricular hypertrophy. Two with essential hypertension and seven with secondary hypertension showed electrocardiographic signs of chronic ischemic heart disease. No patient had ejection fraction less than 50% and none showed signs or symptoms of congestive heart failure, cerebral or peripheral vascular insufficiency. The patients' body mass index was not ≥ 30. All patients refrained from tea, coffee or cigarettes for 36 hours before the study. None was dependent on any drugs.
Written informed consent was obtained from all participants, and the protocol was approved by the Research Committee of S. Orsola Hospital in accordance with the principles of the Declaration of Helsinki.
Experimental procedure
The hyperventilation test was performed between 8 and 12 a.m. in a fasting state and supine position after at least 1 hour in a quiet room. During this period BP and heart rate (HR) were recorded every 5 min. Only subjects with BP values stable for at least 20 min were included in the study. The hyperventilation test was performed by asking the patients to breathe as deeply and rapidly as possible (at least 30 breaths/min) for 5 min. Only those who presented pH values >7.60 in response to hyperventilation were included in the study. During hyperventilation, some patients presented dizziness, Electrocardiogram leads were placed on the chest and a sphygmomanometer cuff was placed on the right arm. Blood samples for the determination of norepinephrine and β-endorphin levels were taken from the left forearm vein immediately before hyperventilation and 2 minutes after the beginning of the test. Previously, we had observed that the major hemodynamic changes in hypertensive patients appeared 2 minutes after the onset of hyperventilation [16] . Arterial blood samples for evaluation of blood gas levels and pH were drawn from the radial or femoral artery immediately after venous blood sampling. HR was monitored continuously by electrocardiography and BP determinations were made at 1 minute intervals throughout the study.
Arterial blood was collected in heparinized syringes and blood gas evaluation was performed by a standard laboratory blood gas analyzer (BG Electrolytes, Instrumentation Laboratory, Barcelona, Spain). Electrocardiogram was recorded by a Cardiostat 3 Siemens electrocardiograph and BP by an automatic Hewlett-Packard 78354A sphygmomanometer. Echo-color-Doppler scans were taken using a monobidimensional mode ATL Mark V machine (Advanced Technology Laboratories, Bothell, Washington).
All procedures followed were in accordance with institutional guidelines.
2.3.Hormone assays
Norepinephrine was determined by column switching HPLC with electrochemical detection as detailed previously [18] . The detection limit was 11.8 fmol/ ml. The intra-assay variation was 3.0% and the interassay variation was 5.1%. The recovery of radiolabeled norepinephrine added to blood samples was over 90%.
Normal plasma values of norepinephrine obtained in elderly normotensive subjects in our laboratory were 500-1500 fmol/ml.
Plasma levels of immunoreactive (ir) ß-endorphinlike material were radioimmunoassayed after chromatographic pre-extraction as previously described [19] . The detection limit was 3 fmol/ml [mean ± S.D. inhibitory concentration (IC 50 ) 15 ± 6 fmol/ml]. The intra-assay and inter-assay variations were <5%. The recovery of radiolabeled peptide added to blood samples was between 84 and 86%. Validation of authenticity of ir-β-endorphin in plasma extract was obtained by rp-HPLC as previously described [19] . Normal plasma values of β-endorphin obtained in our clinical chemistry laboratory were 8-11 fmol/ml.
Statistical analysis
Two-way ANOVA followed by Duncan's test was used to compare hemodynamic and hormonal values recorded during hyperventilation in elderly patients with essential and secondary hypertension.
Hierarchical cluster analyses [20] were carried out to categorize both essential and secondary hypertensive patients into three groups or clusters using percent differences between basal values and successive values of BP, evaluated at time 0 and every minute during the 5 minutes of hyperventilation, as parameters. To verify that the three identified clusters corresponded to distinct populations, we adopted the distribution-free Wilcoxon rank-sum test. Two-way ANOVA was used to compare hemodynamic and hormonal values in each of the three groups of essential and secondary hypertensive subjects. Individual groups were then compared using post hoc Bonferroni's test. The association between BP, HR, norepinephrine and ß-endorphin values obtained in basal conditions and during hyperventilation were analysed by Pearson's r correlation coefficient and regression analysis both in patients with essential and secondary hypertension.
Values are expressed as means ± S.E.M., and p < 0.05 was considered statistically significant.
Results
BP, HR, norepinephrine and β-endorphin levels in basal condition in elderly hypertensive patients
Systolic blood pressure (SBP) and diastolic blood pressure (DBP) in patients with essential hypertension did not significantly differ from the values observed in patients with secondary hypertension, whereas HR levels were significantly (p < 0.05) higher than those in patients with secondary hypertension (Table 2 ). Plasma norepinephrine levels in patients with essential hypertension did not differ from those in patients with secondary hypertension. Circulating levels of β-endorphin in patients with essential hypertension were significantly (p < 0.01) lower than those observed in patients with secondary hypertension (Table 2) .
BP, HR, norepinephrine and β-endorphin levels in response to the hyperventilation test in elderly hypertensive patients
In patients with essential hypertension, hyperventilation significantly (p < 0.01) decreased SBP, DBP and norepinephrine levels, whereas it increased (p < 0.01) HR and β-endorphin levels. In patients with secondary hypertension, hyperventilation did not significantly change SBP, DBP, norepinephrine or β-endorphin levels, whereas it significantly (p < 0.05) increased HR values ( Table 2 ).
BP and HR levels in elderly hypertensive
patients divided according to pressor response to hyperventilation
As hyperventilation induced a wide range of BP responses in patients of both hypertensive populations, we used a hierarchical cluster analysis to divide patients with essential and secondary hypertension on the basis of their BP response to hyperventilation. Three groups (or clusters) of patients were identified ( Table 3) .
Elderly patients with essential hypertension
Among patients with essential hypertension: group 1 (n = 28) had a significant (p < 0.05) decrease in SBP (-11.0%) and DBP (-14.3%) 2 minutes after the onset of hyperventilation; group 2 (n = 6) did not show any significant change in BP; and group 3 (n = 5) had a significant (p < 0.05) increase in SBP (13.8%) and DBP (15.0%) 2 minutes after the onset of hyperventilation. Hyperventilation significantly (p < 0.01) increased HR values with respect to the respective basal values in all groups (Table 4) .
In group 1 the basal values of SBP were higher (p < 0.01) than those in groups 2 and 3 ( Table 4) , whereas the basal DBP levels did not significantly differ among the 3 groups (Table 4) . In group 1 the basal values of HR were higher (p < 0.01) than those in group 3 ( Table 4) .
Arterial blood pH did not differ significantly among the three groups either under basal conditions (group 1: 7.38 ± 0.003; group 2: 7.38 ± 0.004; group 3: 7.39 ± 0.002) or in response to hyperventilation (group 1: 7.62 ± 0.002; group 2: 7.63 ± 0.003; group 3: 7.63 ± 0.003).
Elderly patients with secondary hypertension
Among patients with secondary hypertension: group 1 (n = 4) had a significant (p < 0.05) decrease in SBP (-11.4%) and DBP (-18.7%) 2 minutes after the onset of hyperventilation; group 2 (n = 29) did not show any significant change; and group 3 (n = 6) had a significant (p < 0.05) increase in SBP (12.0%) and DBP (19.5%) 2 minutes after the onset of hyperventilation.
Hyperventilation significantly increased HR (p < 0.01) with respect to the respective basal values in groups 1 and 3 ( Table 4) .
The basal values of SBP and DBP did not significantly differ among the three groups, whereas the basal values of HR in group 1 were higher (p < 0.05) than those in groups 2 and 3 ( Table 4) . Arterial blood pH did not differ significantly among the 3 groups either under basal conditions (group 1: 7.38 ± 0.003; group 2: 7.39 ± 0.003; group 3: 7.38 ± 0.003) or in response to hyperventilation (group 1: 7.63 ± 0.001; group 2: 7.63 ± 0.002; group 3: 7.62 ± 0.001).
Norepinephrine and β-endorphin levels in elderly hypertensive patients divided according to pressor response to hyperventilation
In both patients with essential and secondary hypertension, basal circulating norepinephrine levels in group 1 were significantly (p < 0.05) higher than the values in groups 2 and 3 ( Table 4 ). In both hypertensive populations the decrease in BP in response to hyperventilation observed in group 1 was associated with a significant (p < 0.01) decrease in norepinephrine levels, whereas the increase in BP found in group 3 was accompanied by a significant (p < 0.01) increase in norepinephrine values ( Table 4) .
A significant positive correlation (r = 0.58, p < 0.01) was found between SBP and norepinephrine levels in group 1 of patients with essential hypertension in response to hyperventilation.
Basal levels of β-endorphin of the three groups of patients with essential hypertension were significantly (p < 0.01) lower than the respective values of the three groups of secondary hypertensive patients (Table 4) . In group 1 the basal levels of β-endorphin of patients with essential hypertension were significantly (p < 0.01) lower than those obtained in groups 2 and 3.
A significant negative correlation (r = -0.56, p < 0.01) was found between β-endorphin and norepinephrine values in basal condition in group 1 patients with essential hypertension.
Hyperventilation significantly (p < 0.05) increased β-endorphin in group 1 patients with essential and secondary hypertension, whereas it did not significantly change β-endorphin values in groups 2 and 3 in either hypertensive population (Table 4) .
Significant negative correlations were found between β-endorphin levels and SBP (r = -0.50, p < 0.01) (Figure 1 ) and between β-endorphin and norepinephrine (r = -0.60, p < 0.01) values in response to hyperventilation in group 1 patients with essential hypertension.
Discussion
Our findings indicate that plasma β-endorphin values were normal in elderly patients with essential hypertension and increased in elderly patients with secondary hypertension. Plasma norepinephrine levels were normal in both populations. The hyperventilation test induced a significant decrease in BP and norepinephrine levels associated with an increase in plasma β-endorphin values in patients with essential hypertension, whereas it did not modify BP or neuro-hormonal parameters in patients with secondary hypertension.
The wide range of BP values in response to hyperventilation observed in patients of both populations prompted us to use a hierarchical cluster analysis that disclosed sub-groups with homogeneous BP responses: group 1 exhibited a reduction in BP values, group 2 no change, and group 3 an increase in BP values.
The division into subgroups confirmed a distinct reactivity to hyperventilation between elderly patients with essential hypertension and elderly patients with secondary hypertension. In fact, most (28/39) patients with essential hypertension responded with a significant decrease in BP, whereas most patients with secondary hypertension (29/39) did not show any significant change in pressor response to the test. Interestingly, hemodynamic reactivity to hyperventilation in essential hypertension does not seem to change with aging. In fact the results in elderly patients did not differ from those previously observed in adult patients in whom BP decrease following hyperventilation was the most frequent response [6] .
In elderly essential hypertension the decrease in SBP response to hyperventilation was found in patients with the highest pre-test plasma norepinephrine levels and the lowest β-endorphin levels and was correlated to a decrease in norepinephrine and an increase in β-endorphin levels. Instead, increased BP in response to hyperventilation in essential hypertension was observed in patients with the lowest pre-test norepinephrine and normal β-endorphin levels and the increase in norepinephrine levels in response to the test was not accompanied by changes in β-endorphin values.
The large sub-group of essential hypertensive patients with high baseline plasma norepinephrine levels, identified by cluster analysis as group 1, offers a potential explanation for the contrasting literature data regarding circulating levels of norepinephrine in elderly hypertensive patients [2, 6, 21] . Our findings suggest that elderly patients with essential hypertension form an unbalanced mixture of groups with different sympathoadrenergic activity.
The high norepinephrine levels observed in patients with essential hypertension are consistent with a sympatho-adrenergic hyperactivity that may explain the hypotensive effects of respiratory alkalosis affecting central pressor areas of the autonomic nervous system.
Respiratory alkalosis is a stressor with complex effects on the autonomic nervous and endocrine systems. Hyperventilation may disrupt the autonomic mechanisms controlling the balance between the sympathetic and parasympathetic systems. The effects of hypocapnic alkalosis differ as it stimulates the sympathetic or parasympathetic nervous system according to the basal function of the autonomic nervous system [6] . It may be speculated that the vagal part of the autonomic nervous system preferentially reacts to the respiratory alkalosis in patients in whom the sympatho-adrenergic system is already strongly activated in basal conditions, as observed in elderly essential hypertensive patients. The hyperventilation-induced decrease in BP can be construed as the result of a parasympathetic activation stimulating the endogenous opioid system [22, 23] that, in turn, reduces sympatho-adrenergic activity [24, 25] .
In agreement with these data we observed a negative correlation between the increase in β-endorphin values and the decrease in norepinephrine levels following hyperventilation in elderly essential hypertensive patients responding with a decrease in BP.
Opioids are known to inhibit norepinephrine release [11, 24, 25] and have central inhibitory effects on the pressor area involved in regulating sympatho-adrenergic function [26] . Intravenous administration of β-endorphin produces hypotension in humans and experimental animals [26] . The hypotensive effects of an antihypertensive agent, clonidine, leading to a reduction in plasma norepinephrine concentration and an increase in plasma β-endorphin levels, can be reversed by an opiate antagonist, naloxone [7] .
Elderly patients with essential hypertension who responded to hyperventilation with an increase in BP values did not present an activation of the endogenous opioid system during the test. This is probably because the moderate sympatho-adrenergic activity observed in pre-test conditions may give rise to the stimulant effects of respiratory alkalosis on the sympatho-adrenergic system.
The absence of norepinephrine and β-endorphin changes in patients with secondary hypertension without a significant BP change in response to hyperventilation is consistent with failure by the autonomic nervous system to react to hypocapnic alkalosis. This condition may be explained by the lack of involvement of the central pressor areas in the mechanisms inducing hypertension. The adrenergic hyperactivity in hypertension due to nephroangiosclerosis may depend on the activation of the renin-angiotensin system; the sympathoadrenergic function in isolated systolic hypertension, bilateral chronic nephropathy and hyperparathyroidism has borderline hypertensive effects due to a reflected inhibition on sympathetic nervous control related to the increase in peripheral vascular resistance [27] [28] [29] [30] . The absence of BP response to hyperventilation in diabetic patients confirms a major impairment of the autonomic reflexes controlling the vegetative functions [31] .
Significant pressor changes in response to hyperventilation were found in patients with nephroangiosclerosis and isolated systolic hypertension, in whom the hypertension had arisen in the past as essential hypertension. The autonomic nervous system in these patients may continue to exert a pressor control that is affected by respiratory alkalosis. Moreover, it cannot be ruled out that sympatho-adrenergic tone in some patients with secondary hypertension may be affected in pre-test condition by each individual's emotional predisposition to respond to the condition built into the test.
It is unlikely that the high basal plasma β-endorphin levels in patients with secondary hypertension play a role in the responses to hyperventilation as there is no evidence of impaired endogenous opioid system function in this condition. The increased levels of β-endorphin may depend on inadequate clearance rather than increased release as patients with renal failure have high plasma β-endorphin levels [8, 9] . Our patients with secondary hypertension had high creatinine values and the highest β-endorphin levels were found in those with bilateral chronic nephropathy showing severe renal failure. The high β-endorphin levels found in our diabetic patients were probably related to chronic nephropathy since literature reports in diabetes indicate low circulating levels of the opioid [32, 33] .
In conclusion, our findings indicate that in elderly hypertensive patients with essential hypertension, BP and norepinephrine values do not differ from those in patients with secondary hypertension, but they present lower plasma β-endorphin levels. Cardiovascular and neuro-endocrine responses to the hyperventilation test differentiate the two forms of hypertension: patients with essential hypertension showed a decrease in BP and norepinephrine levels associated with an increase in β-endorphin levels; and patients with secondary hypertension had no significant BP or neuro-hormonal changes. The results in elderly essential hypertensive patients were similar to those previously observed in adult essential hypertensive patients, suggesting that aging does not substantially modify the autonomic nervous system's reactivity to the effects of respiratory alkalosis. The BP response to hyperventilation in elderly essential hypertensive patients is consistent with the effects of hypocapnic alkalosis on the central pressor areas of the autonomic nervous system. A cluster analysis identified a sub-group of patients with essential hypertension with the highest basal levels of norepinephrine and the lowest β-endorphin levels in whom the decrease in BP following hyperventilation was correlated with the decrease in norepinephrine and increase in β-endorphin levels. This suggests that β-endorphin is involved in modulating sympatho-adrenergic activity in elderly patients with essential hypertension. Table 4 . Hemodynamic and neuro-hormonal parameters in elderly hypertensive patients responding to hyperventilation with reduced (group 1), unchanged (group 2) or increased (group 3) blood pressure before (A) and after (B) hyperventilation.
